These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17100711)

  • 1. Hepatitis C virus re-infection: new perspectives.
    Sprinzl MF; Otto G; Galle PR; Schuchmann M
    Clin Transplant; 2006; 20 Suppl 17():117-23. PubMed ID: 17100711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
    Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
    Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
    Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of recurrent hepatitis C and what influences this.
    Gane EJ
    Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel strategies for preventing viral hepatitis C recurrence after liver transplantation].
    Stoll-Keller F; Fafi-Kremer S; Wolf P; Doffoël M; Baumert T
    Bull Acad Natl Med; 2008 Nov; 192(8):1657-67; discussion 1667-8. PubMed ID: 19445379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hepatitis C.
    Marubashi S; Dono K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
    J Hepatobiliary Pancreat Surg; 2006; 13(5):382-92. PubMed ID: 17013711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course and treatment of recurrent Hepatitis C after liver transplantation.
    Neumann UP; Neuhaus P
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):61-6. PubMed ID: 15719007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific hyporesponsiveness in ELISPOT assay is associated with early recurrence of hepatitis C in liver transplant recipients.
    Tambur AR; Ben-Ari Z; Herrera ND; Klein T; Michowiz R; Mor E
    Hum Immunol; 2005 Jan; 66(1):21-7. PubMed ID: 15620458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection in haemodialysis and kidney transplant patients.
    Baid-Agrawal S; Pascual M; Moradpour D; Frei U; Tolkoff-Rubin N
    Rev Med Virol; 2008; 18(2):97-115. PubMed ID: 18064722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.
    Bahra M; Jacob D; Neumann UP; Spies F; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
    Transplantation; 2007 Jul; 84(2):144-8. PubMed ID: 17667804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent hepatitis C after liver transplantation.
    Biggins SW; Terrault NA
    Clin Liver Dis; 2005 Aug; 9(3):505-23, ix. PubMed ID: 16023980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus and liver transplantation.
    Verna EC; Brown RS
    Clin Liver Dis; 2006 Nov; 10(4):919-40. PubMed ID: 17164125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches and therapeutic modalities for the prevention and treatment of recurrent HCV after liver transplantation.
    Davis GL
    Liver Transpl; 2003 Nov; 9(11):S114-9. PubMed ID: 14586906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrence of hepatitis C infection following liver transplantation.
    Charlton M
    Minerva Chir; 2003 Oct; 58(5):717-24. PubMed ID: 14603150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.